Dr. Nauman ChaudhryDr. Nauman Chaudhry, MD

The principal investigator in several pioneering national clinical trials.

Dr. Nauman Chaudhry was presented the Honor Award by the American Society of Retina Specialists (ASRS) for his academic contributions. He is also an active member of the prestigious, invitation-only Retina Society and Macula Society.

Dr. Chaudhry is a vitreo-retinal surgeon, completing his residency at the Yale Eye Center in New Haven where he served as chief resident. He was awarded the Marvin Sears Award for Excellence in Clinical Ophthalmology. This is usually given to Yale’s best senior ophthalmology resident, but he was awarded as a junior resident. Dr. Chaudhry completed a second residency at the Bascom Palmer Eye Institute at the University of Miami, where he also finished his medical and surgical retina fellowship. Bascom Palmer has been consistently named the best eye hospital in the United States by U.S. News & World Report.

Dr. Chaudhry also had the distinguished honor of being in the top one percentile for both parts of the United States Medical Licensing Exam (USMLE). This written exam is taken by thousands of American and international medical doctors every year prior to residency training.

Dr. Chaudhry is currently an Assistant Clinical Professor of Ophthalmology at the Yale School of Medicine. He is board-certified in Ophthalmology and serves as an examiner for the American Board of Ophthalmology. He is also a scientific reviewer for the prestigious Archives of Ophthalmology and Retina.

Dr. Chaudhry has authored more than 90 papers and abstracts in peer-reviewed ophthalmology literature. His research has included topics in retinal detachment, diabetic retinopathy, age-related macular degeneration, macular holes, ocular trauma, endophthalmitis and ocular complications. He is currently the principal investigator in several pioneering national clinical trials for the treatment of age-related macular degeneration, vein occlusions and diabetic macular edema. He is the only principal clinical investigator in Connecticut who was invited to participate in all enrolled Phase 3 clinical trials of the new FDA-approved drug Eylea, which is now a frontline treatment for wet macular degeneration with potential for use for other blinding retinal diseases.

Dr. Chaudhry is accepting new patients in our New London, Norwich and Branford offices.


Juner M. Colina-Biscotto, MDDr. Juner M. Colina-Biscotto, MD

Dr. Colina-Biscotto is Board Certified; she received her medical degree from the Central University of Venezuela School of Medicine. She was awarded the Fundayacucho National Excellence Scholarship for her academic performance. She was then accepted into the most prestigious ophthalmology training program in Venezuela at the Hospital J. A. Risquez. She graduated from J. A. Risquez with honors and went on to win an international fellowship at the Association to Prevent Blindness in Mexico (APEC), at Luis Sanchez Bulnes Hospital in Mexico City.

The APEC program is recognized as one of the top training experiences for vitreo-retinal diseases in the world.  Here, she worked under the guidance of Hugo Quiroz-Mercado, a world-renowned retinal surgeon. In his words, “She is simply the best retinal surgeon of the thousands of retinal surgeons I have ever trained.”

Dr. Colina Biscotto also worked for two years in retina research at New England Retina Associates.  She worked closely with all of the ophthalmologists, learning additional techniques, assisting surgery, and serving patients with exceptional care. She has also done extensive work on the treatment of ocular melanoma and other tumors.

In order to meet the American Board of Ophthalmology requirements, Dr. Colina-Biscotto completed a second surgical internship at the Washington Hospital Center in Washington, D.C., and an ophthalmology residency program at the University of Chicago Medical Center in Chicago, where she served as chief resident.

Following her residency training, Dr. Colina-Biscotto sought more advanced training in retina surgery at El Salvador Hospital in Chile. This is a world-renowned tertiary hospital that serves only the most difficult vitreo-retinal surgical cases in South America.

Currently, Dr. Colina-Biscotto is an Assistant Clinical Professor of Ophthalmology at the Yale School of Medicine. She has published numerous articles in peer-reviewed journals and has lectured at multiple international meetings. She is an active member of the American Academy of Ophthalmology, American Society of Retina Specialist (ASRS) and the Pan American Association of Ophthalmology.

Dr. Colina-Biscotto is fluent in English and Spanish. She is currently accepting patients in our New London, Norwich and Branford offices.